Skip to main
ACHC

Acadia Healthcare (ACHC) Stock Forecast & Price Target

Acadia Healthcare (ACHC) Analyst Ratings

Based on 13 analyst ratings
Buy
Strong Buy 31%
Buy 23%
Hold 38%
Sell 8%
Strong Sell 0%

Bulls say

Acadia Healthcare Co Inc has demonstrated a positive trajectory in its operations, achieving a 3% year-over-year increase in same-store admissions due to effective referral source action plans, indicating its ability to enhance patient inflow despite softer patient days. The company anticipates a significant rise in its net PLGL liability by the end of 2025, reflecting proactive financial management and a strategic outlook on handling claims, while also planning a substantial reduction in capital expenditures by $300 million year-over-year in 2026, which is expected to bolster cash flow. Furthermore, Acadia's robust capacity for mergers and acquisitions, coupled with strong demand in the behavioral health sector and impressive organic growth through facility expansions and new developments, positions the company favorably for continued market success.

Bears say

Acadia Healthcare Co Inc has faced continuous downward revisions to its guidance due to underestimating PLGL expenses and experiencing ongoing volume softness, leading to significant reductions in adjusted EBITDA expectations for both 2025 and 2026. The projected EBITDA for 2025 has declined by $32.5 million, while the estimate for 2026 was lowered to $664.6 million, reflecting persistent reimbursement headwinds and operational challenges. Overall prospects remain gloomy as the company's shift towards lower capital expenditures and limited growth in bed availability may hinder its ability to achieve sustainable revenue recovery.

Acadia Healthcare (ACHC) has been analyzed by 13 analysts, with a consensus rating of Buy. 31% of analysts recommend a Strong Buy, 23% recommend Buy, 38% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Acadia Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Acadia Healthcare (ACHC) Forecast

Analysts have given Acadia Healthcare (ACHC) a Buy based on their latest research and market trends.

According to 13 analysts, Acadia Healthcare (ACHC) has a Buy consensus rating as of Feb 7, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $19.62, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $19.62, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Acadia Healthcare (ACHC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.